This exhibit processes the application of extra-articular injections of prednisolone tertiary butylacetate with or without hexylcaine hydrochloride for tendon, ligament, muscle, and bursal pathology of an acute or chronic nature which has been resistant to traditional therapy. It has been found that these injections tended to (1) alleviate muscle spasm, (2) reduce the inflammatory process, (3) decrease the pain, and (4) shorten the course of the disease and the duration of its disability.
The only contraindications are acute infections, blood dyscrasias, and malignancies.
The rational use of muscle relaxants, analgesics, and various modalities of physical therapy in conjunction with these extra-articular injections have made it possible to institute earlier muscle reeducation and motion. Hence, modality has been decreased and the period of rehabilitation substantially shortened.
The dosage of prednisolone tertiary butylacetate (Hydeltra T. B. A., Merck, Sharpe & Dohme) is shown in the accompanying key. The dose of hexylcaine
LIPOW EG, KRON KM, SMITH RT. Technique for Extra-Articular Injection. AMA Arch Surg. 1958;76(1):171–178. doi:10.1001/archsurg.1958.01280190173034
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: